Letter · 2015
OtherPublished 26 Jul 2016
Lanthanum carbonate
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hyperphosphatemia is associated with increased mortality in patients with end-stage renal disease. Unfortunately, precise, effective control of serum phosphate levels cannot be achieved by dialysis and regulation of dietary phosphate alone. For most patients, effective, safe and convenient phosphate binders are needed. Preclinical studies demonstrate that the new phosphate binder, lanthanum carbonate, has potent phosphate-binding properties at clinically relevant pH levels, and indicate that almost all the lanthanum phosphate formed passes unchanged through the gut. Plasma levels of lanthanum are limited and noncumulative, and the minimal systemic fraction has nonrenal elimination. Clinical trials show that lanthanum carbonate, taken with food, can effectively control hyperphosphatemia in dialysis patients, and has a well-tolerated safety profile. Side effects are largely gastrointestinal and are generally mild to moderate. Lanthanum carbonate treatment may prove instrumental in achieving the increasingly stringent target serum phosphate levels in patients with end-stage renal disease.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2014
Pilot Study of the Effect of Lanthanum Carbonate (Fosrenoland#174;) In Patients with Calciphylaxis: A Wisconsin Network for Health Research (WiNHR) Study
Research article · 2014
Pilot Study of the Effect of Lanthanum Carbonate (Fosrenol®) In Patients with Calciphylaxis: A Wisconsin Network for Health Research (WiNHR) Study
Research article · 2016
Cost-minimization Analysis between Sevelamer and Lanthanum in Treating Hyperphosphatemia among Patients with End-stage Renal Disease in China
Research article · 3 May 2019
Synthesis and Effect of Eu Dopant on PL and Crystallites size of lanthanum Phosphate: LaPO4:Eu3+
More from this journal
The newest in Clinical Practice.
Article · 20 May 2025
Histological effects of doxorubicin and baobab plants on some organs of rat
Article · 20 May 2025
Histological effects of doxorubicin and baobab plants on some organs of rat
Article · 28 Mar 2025
Using
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “William F Finn”
